<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article article-type="research-article" xml:lang="en"><?DTDIdentifier.IdentifierValue thiemejournals.xsd?><?DTDIdentifier.IdentifierType nschema?><?SourceDTD.DTDName thiemejournals.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName thiemexml2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Planta Med</journal-id><journal-id journal-id-type="iso-abbrev">Planta Med</journal-id><journal-id journal-id-type="doi">10.1055/s-00000058</journal-id><journal-title-group><journal-title>Planta Medica</journal-title></journal-title-group><issn pub-type="ppub">0032-0943</issn><issn pub-type="epub">1439-0221</issn><publisher><publisher-name>Georg Thieme Verlag KG</publisher-name><publisher-loc>Stuttgart &#x000b7; New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1055/s-0033-1360277</article-id><article-categories><subj-group><subject>Biological and Pharmacological Activity</subject><subj-group><subject>Original Papers</subject></subj-group></subj-group></article-categories><title-group><article-title>Kaempferol Derivatives as Antiviral Drugs against the 3a Channel
Protein of Coronavirus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schwarz</surname><given-names>Silvia</given-names></name><xref rid="AFX0969-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Sauter</surname><given-names>Daniel</given-names></name><xref rid="AFX0969-1" ref-type="aff">1</xref><xref rid="AFX0969-2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Kai</given-names></name><xref rid="AFX0969-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ronghua</given-names></name><xref rid="AFX0969-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Bing</given-names></name><xref rid="AFX0969-3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Karioti</surname><given-names>Anastasia</given-names></name><xref rid="AFX0969-4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Bilia</surname><given-names>Anna Rita</given-names></name><xref rid="AFX0969-4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Efferth</surname><given-names>Thomas</given-names></name><xref rid="AFX0969-5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Schwarz</surname><given-names>Wolfgang</given-names></name><xref rid="AFX0969-1" ref-type="aff">1</xref><xref rid="AFX0969-2" ref-type="aff">2</xref><xref rid="CO-1" ref-type="author-notes"/></contrib></contrib-group><aff id="AFX0969-1"><label>1</label><institution>Shanghai Research Center for Acupuncture &#x00026; Meridians, Shanghai,
China</institution></aff><aff id="AFX0969-2"><label>2</label><institution>Institute for Biophysics, JW-Goethe-University, Frankfurt a.&#x0200a;M.,
Germany</institution></aff><aff id="AFX0969-3"><label>3</label><institution>Key Laboratory of Molecular Virology &#x00026; Immunology, Institut Pasteur
of Shanghai, Shanghai Chinese Academy of Sciences, Shanghai, China</institution></aff><aff id="AFX0969-4"><label>4</label><institution>Department of Chemistry, Building of Pharmaceutical Sciences,
University of Florence, Sesto Fiorentino (FI), Italy</institution></aff><aff id="AFX0969-5"><label>5</label><institution>Institute for Pharmacology and Biochemistry, J-Gutenberg University,
Mainz, Germany</institution></aff><author-notes><corresp id="CO-1"><bold>Correspondence </bold>Wolfgang Schwarz <institution>Institute for Biophysics, JW-Goethe University</institution><addr-line>Max-von-Laue Str. 1</addr-line><addr-line>60438 Frankfurt a. M.</addr-line><addr-line>Germany</addr-line><phone>+49 69 79 84 64 01</phone><email>wolfgang.schwarz@email.de</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>1</month><year>2014</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2014</year></pub-date><volume>80</volume><issue>02-03</issue><fpage>177</fpage><lpage>182</lpage><history><date date-type="received"><day>14</day><month>9</month><year>2013</year></date><date date-type="rev-recd"><day>02</day><month>12</month><year>2013</year></date>accepted <date date-type="accepted"><day>13</day><month>12</month><year>2013</year></date></history><permissions><license license-type="open-access"><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><abstract><p>The protein coded by the open-reading-frame 3a of SARS coronavirus has been
demonstrated to form a cation-selective channel that may become expressed in
the infected cell. The activity of the channel is involved in the mechanism
of virus release. Drugs that inhibit the ion channel can, therefore, inhibit
virus release, and they could be a source for development of novel
therapeutic antiviral agents. Various drugs found in Chinese herbs that are
well known as anticancer agents also have an antiviral potency. Here we
tested the flavonols kaempferol, kaempferol glycosides, and acylated
kaempferol glucoside derivatives with respect to their potency to block the
3a channel. We used the <italic>Xenopus</italic> oocyte with a heterologously
expressed 3a protein as a model system to test the efficacy of the
flavonols. Some of these drugs turned out to be potent inhibitors of the 3a
channel. The most effective one was the glycoside juglanin (carrying an
arabinose residue) with an IC<sub>50</sub> value of 2.3&#x02009;&#x000b5;M for inhibition of
the 3a-mediated current. Kaempferol derivatives with rhamnose residue also
seem to be quite effective. We suggest that viral ion channels, in general,
may be a good target for the development of antiviral agents, and that, in
particular, kaempferol glycosides are good candidates for 3a channel
proteins of coronaviruses.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>coronavirus</kwd><kwd>virus release</kwd><kwd>ion channel</kwd><kwd>kaempferol derivatives</kwd><kwd>flavonoids</kwd></kwd-group></article-meta></front><body><sec><def-list><title>Abbreviations</title><def-item><term>CoV</term><def><p>coronavirus</p></def></def-item><def-item><term>ORF</term><def><p>open reading frame</p></def></def-item><def-item><term>ORi</term><def><p>oocyte Ringer&#x002bc;s</p></def></def-item><def-item><term>G-ORi</term><def><p>ORi supplemented with gentamycin</p></def></def-item><def-item><term>NMR</term><def><p>nuclear magnetic resonance</p></def></def-item><def-item><term>SARS</term><def><p>severe acute respiratory syndrome</p></def></def-item><def-item><term>S1</term><def><p>test solution without Ba<sup>2+</sup></p></def></def-item><def-item><term>S2</term><def><p>test solution with 10&#x02009;mM Ba<sup>2+</sup></p></def></def-item></def-list></sec><sec><title>Introduction</title><p>Various herbal antiviral drugs have been developed that interfere with the viral life
cycle <xref rid="RX0969-1" ref-type="bibr">1</xref>. During the first appearance of SARS about
50&#x0200a;% of the patients in mainland China were treated successfully with Chinese herbal
medicine in addition to Western medicine <xref rid="RX0969-2" ref-type="bibr">2</xref>,&#x0200a;<xref rid="RX0969-3" ref-type="bibr">3</xref>.</p><p>Several viruses encode for ion-selective channels that become incorporated into the
membrane of the infected cell <xref rid="RX0969-4" ref-type="bibr">4</xref>,&#x0200a;<xref rid="RX0969-5" ref-type="bibr">5</xref>,&#x0200a;<xref rid="RX0969-6" ref-type="bibr">6</xref>,&#x0200a;<xref rid="RX0969-7" ref-type="bibr">7</xref>. Activation of such channels seems to be involved in
the process of virus production and release <xref rid="RX0969-8" ref-type="bibr">8</xref>,&#x0200a;<xref rid="RX0969-9" ref-type="bibr">9</xref>,&#x0200a;<xref rid="RX0969-10" ref-type="bibr">10</xref>,&#x0200a;<xref rid="RX0969-11" ref-type="bibr">11</xref>,&#x0200a;<xref rid="RX0969-12" ref-type="bibr">12</xref>. Hence,
inhibition of the ion channel activation will counteract virus production; this may
allow the infected body to build up or strengthen its own immune system. The viral
ion channel will, therefore, be a potential candidate for developing new antiviral
drugs. The ORF 3a of SARS CoV encodes for an ion-permeable channel. We could
previously demonstrate that micromolar concentrations of the anthraquinone emodin
can inhibit the 3a channel activity with an IC<sub>50</sub> value of only 20&#x02009;&#x000b5;M and
also inhibit coronavirus release with a similar sensitivity from infected cells
<xref rid="RX0969-13" ref-type="bibr">13</xref>. This indicates that the viral ion channel is
an interesting target for antiviral drugs.</p><p>Emodine as well as various flavonoids (<xref rid="FIX0969-1" ref-type="fig">Fig.&#x02009;1</xref>) are
well known to act as anticancer drugs <xref rid="RX0969-14" ref-type="bibr">14</xref>,&#x0200a;<xref rid="RX0969-15" ref-type="bibr">15</xref>, but they were also discussed as antiviral drugs
<xref rid="RX0969-16" ref-type="bibr">16</xref>. The flavonol kaempferol and its glycosides
have been reported previously to have high antiviral activity <xref rid="RX0969-1" ref-type="bibr">1</xref>, but effects on the intracellular events were favoured as an
explanation <xref rid="RX0969-17" ref-type="bibr">17</xref>,&#x0200a;<xref rid="RX0969-18" ref-type="bibr">18</xref>.
Here we investigated whether the flavonol kaempferol and kaempferol glycosides can
block the 3a channel. In addition, we tested a number of other flavonoids (<xref rid="FIX0969-1" ref-type="fig">Fig.&#x02009;1</xref>). This manuscript extends preliminary data <xref rid="RX0969-1" ref-type="bibr">1</xref> to investigate the role of this class of compounds in
more detail.</p><fig id="FIX0969-1"><label>Fig.&#x02009;1</label><caption><p>
&#x02003;Structure of the flavonoids tested with respect to their effects on
the 3a-mediated current. The flavonol kaempferol (<bold>1</bold>) and the kaempferol
glycosides afzelin (<bold>2</bold>), juglanine (<bold>3</bold>), and tiliroside (<bold>4</bold>),
as well as two tiliroside derivatives (<bold>5</bold>&#x02013;<bold>6</bold>), the kaempferol
triglycoside (<bold>7</bold>), the flavonol quercetin (<bold>8</bold>), the flavanone
naringenin (<bold>9</bold>), and the isoflavone genistein (<bold>10</bold>). Rha stands for
rhamnose and Araf for arabinofuranose. For their respective effects, compare
<xref rid="TBX0969-1" ref-type="table">Table 1</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pm01"/></fig></sec><sec><title>Results and Discussion</title><p>The flavonoids listed in <xref rid="TBX0969-1" ref-type="table">Table 1</xref> are well known for
their anticancer activity, but also various antiviral effects have been reported
<xref rid="RX0969-18" ref-type="bibr">18</xref>,&#x0200a;<xref rid="RX0969-19" ref-type="bibr">19</xref>,&#x0200a;<xref rid="RX0969-20" ref-type="bibr">20</xref>. Here we investigated these drugs with respect to
their efficacy to inhibit Ba<sup>2+</sup>-sensitive current. <xref rid="FIX0969-2" ref-type="fig">Fig.&#x02009;2&#x0200a;a</xref> shows that 20&#x02009;&#x000b5;M kaempferol reduced endogenous
Ba<sup>2+</sup>-sensitive current. At &#x02212;&#x02009;100&#x02009;mV the current was inhibited to
0.77&#x02009;&#x000b1;&#x02009;0.08 (p&#x02009;&#x0003c;&#x02009;0.01) of the control current in the absence of the drug. The
degree of inhibition was independent of voltage.</p><fig id="FIX0969-2"><label>Fig.&#x02009;2</label><caption><p>
&#x02003;Effect of kaempferol on current-voltage (IV) curves of
Ba<sup>2+</sup>-sensitive current. Open squares describe the current-voltage
dependencies in the absence and filled squares in the presence of 20&#x02009;&#x000b5;M
kaempferol. <bold>a</bold>&#x02002;Endogenous currents, <bold>b</bold>&#x02002;currents of cells with
heterologously expressed 3a protein, and <bold>c</bold>&#x02002;the 3a-protein-mediated
current component (endogenous current subtracted). Data represent averages of
n&#x02009;=&#x02009;4 to 7 experiments &#x000b1; SEM.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pm02ac"/></fig><table-wrap id="TBX0969-1"><caption><p>
<bold>Table 1</bold>&#x02003;Effect of drugs on a 3a-mediated current. Current
remaining in the presence of the respective drug concentration is
expressed as ratio compared to control current in the absence of drug;
values are given as mean &#x000b1;SEM, based on n measurements. The values were
determined from currents at &#x02212;&#x02009;100&#x02009;mV. Two of the kaempferol glycosides
were, in addition to 20&#x02009;&#x000b5;M, also tested at 40&#x02009;&#x000b5;M. Statistical difference
from the control value was determined by t-test and is given by the p
value; sns stands for statistically not significant
(p&#x02009;&#x0003e;&#x02009;0.2).</p></caption><table rules="all"><colgroup><col width="0"/><col width="0"/><col width="0"/><col width="0"/><col width="0"/><col width="0"/><col width="0"/></colgroup><thead><tr><th/><th align="left">Drug</th><th align="left">Purity (%)</th><th align="left">Concentration (&#x000b5;M)</th><th align="left">Remaining current (relative to control)</th><th align="left">n</th><th align="left">p</th></tr></thead><tbody><tr><td rowspan="7">Kaempferol glycosides</td><td>Kaempferol</td><td>&#x0003e;&#x02009;97</td><td>20</td><td>0.82&#x02009;&#x000b1;&#x02009;0.01</td><td>7</td><td>&#x0003c;&#x02009;0.01</td></tr><tr><td>Juglanin</td><td>98</td><td>20 10</td><td>Complete inhibition 0.01&#x02009;&#x000b1;&#x02009;0.06</td><td>5</td><td>&#x0003c;&#x02009;0.01</td></tr><tr><td>Tiliroside</td><td>&#x0003e;&#x02009;95</td><td>20</td><td>0.48&#x02009;&#x000b1;&#x02009;0.09</td><td>5</td><td>&#x0003c;&#x02009;0.01</td></tr><tr><td>Afzelin</td><td>98</td><td>10</td><td>0.83&#x02009;&#x000b1;&#x02009;0.01</td><td>5</td><td>&#x0003c;&#x02009;0.01</td></tr><tr><td>Kaempferol-3-O-(2,6-di-<italic>p</italic>-coumaroyl)-glucoside</td><td>&#x0003e;&#x02009;95</td><td>20 (40)</td><td>No effect</td><td>8</td><td>sns</td></tr><tr><td>Kaempferol-3-O-(3,4-diacetyl-2,6-di-<italic>p</italic>-coumaroyl)-glucoside</td><td>&#x0003e;&#x02009;95</td><td>20 (40)</td><td>No effect</td><td>8</td><td>sns</td></tr><tr><td>Kaempferol-3-O-<italic>&#x003b1;</italic>-rhamnopyranosyl(1&#x02009;&#x02192;&#x02009;2)
[<italic>&#x003b1;</italic>-rhamnopyranosyl(1&#x02009;&#x02192;&#x02009;6)]-<italic>&#x003b2;</italic>-glucopyranoside</td><td>&#x0003e;&#x02009;95</td><td>20</td><td>0.68&#x02009;&#x000b1;&#x02009;0.11</td><td>4</td><td>&#x0003c;&#x02009;0.05</td></tr><tr><td rowspan="3">Other flavonoids</td><td>Quercetin</td><td>&#x0003e;&#x02009;95</td><td>10</td><td>0.91&#x02009;&#x000b1;&#x02009;0.10</td><td>8</td><td>sns</td></tr><tr><td>Naringenin</td><td>98</td><td>20</td><td>0.93&#x02009;&#x000b1;&#x02009;0.05</td><td>4</td><td>sns</td></tr><tr><td>Genistein</td><td>&#x0003e;&#x02009;96</td><td>20</td><td>0.91&#x02009;&#x000b1;&#x02009;0.15</td><td>5</td><td>sns</td></tr></tbody></table></table-wrap><p>In oocytes with expressed 3a protein, Ba<sup>2+</sup>-sensitive current was larger by
a factor of about 3 to 5 than in control oocytes (compare <xref rid="FIX0969-2" ref-type="fig">Fig.&#x02009;2&#x0200a;a</xref> and <xref rid="FIX0969-2" ref-type="fig">b</xref>). Kaempferol also affected
this additional 3a-mediated current component (<xref rid="FIX0969-2" ref-type="fig">Fig.&#x02009;2&#x0200a;b</xref>). After subtraction of the endogenous contribution (<xref rid="FIX0969-2" ref-type="fig">Fig.&#x02009;2&#x0200a;c</xref>), the current at &#x02212;&#x02009;100&#x02009;mV was reduced to
0.82&#x02009;&#x000b1;&#x02009;0.10 of the current component in the absence of drug; this indicated that the
endogenous and the 3a-mediated components exhibited similar sensitivity to
kaempferol. This is in contrast to emodin which selectively inhibited the
3a-mediated current and at 20&#x02009;&#x000b5;M already produced more than 50&#x0200a;% block (see <xref rid="RX0969-13" ref-type="bibr">13</xref>). The poor solubility of kaempferol in water did not
allow testing a higher concentration for evaluation of an IC<sub>50</sub> value. We
therefore did not further follow up the effect of kaempferol, but rather screened
for the effect of various other flavonoids. In particular, the glycosides (<xref rid="TBX0969-1" ref-type="table">Table 1</xref>) are water-soluble and in addition exhibit
higher bioavailability <xref rid="RX0969-21" ref-type="bibr">21</xref>.</p><p>In contrast to kaempferol, the tested kaempferol glycosides hardly affected
Ba<sup>2+</sup>-sensitive endogenous current (for juglanin see, e.g., <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;a</xref>). In oocytes with an expressed 3a protein,
stronger effects could be detected than with kaempferol (compare <xref rid="TBX0969-1" ref-type="table">Table 1</xref>). Juglanin seemed to be the most potent
kaempferol glycoside that gave complete inhibition at 20&#x02009;&#x000b5;M; even 10&#x02009;&#x000b5;M produced
nearly complete inhibition. Therefore, we focussed on this drug for a more detailed
analysis. <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;b</xref> illustrates the effect of two
concentrations on the current-voltage dependencies of Ba<sup>2+</sup>-sensitive
current in 3a protein-expressing oocytes. Already 2.5&#x02009;&#x000b5;M exhibited a significant
inhibition. The dependence of the 3a-mediated current component on juglanin
concentration is shown in <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;c</xref>. The dashed line
is a fit to the data of</p><fig id="FIX0969-3"><label>Fig.&#x02009;3</label><caption><p>
&#x02003;Effect of kaempferol glycosides on Ba<sup>2+</sup>-sensitive and
3a-mediated current. Results in the absence of drug are given by open squares
and in the presence of drug by filled symbols. <bold>a</bold>&#x02002;Effect of 10&#x02009;&#x000b5;M juglanin
on current-voltage dependencies of Ba<sup>2+</sup>-sensitve current in control
oocytes without a 3a protein. <bold>b</bold>&#x02002;Effect of 2.5 (filled squares) and 10&#x02009;&#x000b5;M
(filled circles) juglanin on 3a-mediated current that was determined as the
difference of Ba<sup>2+</sup>-sensitive current in a 3a-expressing cells. Data
points represent averages from 4&#x02013;7 experiments &#x000b1;&#x02009;SEM. <bold>c</bold>&#x02002;Inhibition of a
3-mediated current at &#x02212;&#x02009;100&#x02009;mV by juglanin. The data points represent averages
&#x000b1;&#x02009;SEM of 5&#x02013;17 measurements. The dashed line is an approximation of equ. 1 to the
data points with n&#x02009;=&#x02009;1.2 and K<sub>1/2</sub>&#x02009;=&#x02009;2.3&#x02009;&#x000b5;M. <bold>d</bold>&#x02002;Effect of 20&#x02009;&#x000b5;M
tiliroside (squares) and 10&#x02009;&#x000b5;M afzelin (circles) on voltage dependence of a
Ba<sup>2+</sup>-sensitive current in 3a-expressing cell. Data points
represent averages from 4&#x02013;7 experiments &#x000b1;&#x02009;SEM.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pm03ad"/></fig><disp-formula id="DF-1"><alt-text>I_3a-mediated = IC_50^n / (IC_50^n + [juglanin]^n)</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pmeq01.gif"/></disp-formula><p>At a concentration of about 2.3&#x02009;&#x000b5;M juglanin, 50&#x0200a;% inhibition (IC<sub>50</sub>) was
obtained. Hence juglanin is about one order of magnitude more potent to block
3a-protein channel than emodine <xref rid="RX0969-13" ref-type="bibr">13</xref>. With an even
higher IC<sub>50</sub> value of 200&#x02009;&#x000b5;M, emodine was shown to inhibit interaction
between virus and host cell, which was considered to be a potent mechanism in herbal
treatment of SARS <xref rid="RX0969-22" ref-type="bibr">22</xref>. The higher sensitivity of the
3a channel makes this protein an even more interesting target for drug
development.</p><p>Two other tested kaempferol glycosides, tiliroside and afzelin, were less potent than
juglanin but were nevertheless as effective as emodine. Tiliroside at 20&#x02009;&#x000b5;M produced
a block to 0.48&#x02009;&#x000b1;&#x02009;0.09 (<xref rid="TBX0969-1" ref-type="table">Table 1</xref> and <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;d</xref>); at the same concentration, juglanin
completely blocked the 3a-mediated current (<xref rid="TBX0969-1" ref-type="table">Table 1</xref>
and <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;b</xref> and <xref rid="FIX0969-3" ref-type="fig">d</xref>). A
similar degree of inhibition as with 20&#x02009;&#x000b5;M kaempferol was obtained with only 10&#x02009;&#x000b5;M
of afzelin (inhibition to 0.83&#x02009;&#x000b1;&#x02009;0.01) compared to the current in the absence of
drug (<xref rid="TBX0969-1" ref-type="table">Table 1</xref> and <xref rid="FIX0969-3" ref-type="fig">Fig.&#x02009;3&#x0200a;d</xref>).</p><p>In a series of experiments, we also tested the acylated kaempferol derivatives
kaempferol-3-O-(2,6-di-<italic>p</italic>-coumaroyl)-glucopyranoside and
kaempferol-3-O-(3,4-diacetyl-2,6-di-<italic>p</italic>-coumaroyl)-glucoside, which all had
an additional <italic>p</italic>-coumaroyl group (see <xref rid="FIX0969-1" ref-type="fig">Fig.&#x02009;1</xref>).
At 20&#x02009;&#x000b5;M, both derivatives showed no effect on Ba<sup>2+</sup>-sensitive current.
Even at concentrations up to 40&#x02009;&#x000b5;M (<xref rid="TBX0969-1" ref-type="table">Table 1</xref>), no
significant inhibition could be detected. On the other hand, in a few orientating
experiments, we found that the kaempferol triglycoside
kaempferol-3-O-<italic>&#x003b1;</italic>-rhamnopyranosyl(1&#x02009;&#x02192;&#x02009;2)[<italic>&#x003b1;</italic>-rhamnopyranosyl(1&#x02009;&#x02192;&#x02009;6)]-<italic>&#x003b2;</italic>-glucopyranoside
exhibited about 30&#x0200a;% inhibition at 20&#x02009;&#x000b5;M (<xref rid="TBX0969-1" ref-type="table">Table 1</xref>);
this was similar to the effect of afzelin which was also applied at 20&#x02009;&#x000b5;M in two of
these experiments. Interestingly, both drugs are characterized by rhamnose residues
(see <xref rid="FIX0969-1" ref-type="fig">Fig.&#x02009;1</xref>).</p><p>As another flavonol, we tested the effect of quercetin, which was reported to also
act as an effective drug against virus infections including SARS CoV <xref rid="RX0969-23" ref-type="bibr">23</xref>. We found that the 3a-mediated current was not
significantly affected by 10&#x02009;&#x000b5;M quercetin (see <xref rid="TBX0969-1" ref-type="table">Table
1</xref>); concentrations even up to 50&#x02009;&#x000b5;M hardly affected the 3a-mediated
current. Also the quercetin derivative with an arabinofuranoside, avicularin (not
shown), was without any effect.</p><p>The flavanone naringenin and the isoflavone genistein are also known for their
antiviral potency (see, e.g., <xref rid="RX0969-24" ref-type="bibr">24</xref>,&#x0200a;<xref rid="RX0969-25" ref-type="bibr">25</xref>,&#x0200a;<xref rid="RX0969-26" ref-type="bibr">26</xref>), but neither
naringenin nor genistein exhibited any significant modulation of the 3a-mediated
current (see <xref rid="TBX0969-1" ref-type="table">Table 1</xref>).</p><p>Though the flavonols quercetin and avicularin, the flavanone naringenin, and the
isoflavone genistein do not affect the activity of the 3a protein, the flavonol
kaempferol exhibits a clear inhibition of the 3a-mediated current; the kaempferol
glycosides are even more potent inhibitors thus suggesting an importance of sugar
residues. The most potent drug was the kaempferol glycoside juglanin with an
arabinose residue. Interestingly, the kaempferol glycoside afzelin and the
triglycoside with rhamnose residues seem also to be quite effective. In addition to
the higher effectivity of the flavonoid glycosides to inhibit the 3a protein ion
channel, they show higher solubility in water with higher bioactivity <xref rid="RX0969-19" ref-type="bibr">19</xref>,&#x0200a;<xref rid="RX0969-21" ref-type="bibr">21</xref>.</p><p>Though flavonoid glycosides may be absorbed in the small intestine, biodegradation
will limit their therapeutical application, and levels in plasma are probably below
1&#x02009;&#x000b5;M <xref rid="RX0969-21" ref-type="bibr">21</xref>. An important task for developing new
antiviral drugs will therefore have to focus on improving bioactivity <xref rid="RX0969-27" ref-type="bibr">27</xref>; several strategies have been tackled for increasing
bioavailability including drug delivery and metabolic stability (compare <xref rid="RX0969-19" ref-type="bibr">19</xref>,&#x0200a;<xref rid="RX0969-21" ref-type="bibr">21</xref>,&#x0200a;<xref rid="RX0969-27" ref-type="bibr">27</xref>,&#x0200a;<xref rid="RX0969-28" ref-type="bibr">28</xref>).</p><p>Activity of the 3a protein results in ion channel gating which allows small cations
to cross the membrane. Although the channel shows selectivity for K<sup>+</sup>,
also Na<sup>+</sup> can penetrate with slightly lower permeability <xref rid="RX0969-11" ref-type="bibr">11</xref>. As a consequence, activity of channel openings will
lead to membrane depolarization, and activation of L-type Ca<sup>2+</sup> channels
<xref rid="RX0969-29" ref-type="bibr">29</xref> to an elevation of intracellular
Ca<sup>2+</sup>
<xref rid="RX0969-30" ref-type="bibr">30</xref>. This could account for the 3a-protein-dependent
release of CoV from infected cells via exocytosis. Indeed, inhibition of 3a channel
activity blocks virus release; this could be demonstrated by suppression of 3a
expression as well as pharmacological inhibition of the 3a channel <xref rid="RX0969-11" ref-type="bibr">11</xref>,&#x0200a;<xref rid="RX0969-13" ref-type="bibr">13</xref>. This reduction
in virus production offers the body the chance to adjust its immune system to
counteract the viral attack. Inhibition of ion channels encoded by other viruses
could also be demonstrated to inhibit the respective virus production <xref rid="RX0969-31" ref-type="bibr">31</xref>,&#x0200a;<xref rid="RX0969-32" ref-type="bibr">32</xref>,&#x0200a;<xref rid="RX0969-33" ref-type="bibr">33</xref>.</p><p>As a conclusion, we suggest that emodin and kaempferol could form the basis for the
development of new antiviral drugs with higher bioavailability. In particular, the
glycosides of kaempferol seem to be highly potent candidates for development as
anti-coronaviral agents. The fact that these drugs not only block the 3a channel,
thus counteracting virus production, but that they also interfere with other steps
of the viral life cycle <xref rid="RX0969-20" ref-type="bibr">20</xref> emphasises the importance
of multi-target drugs.</p></sec><sec><title>Materials and Methods</title><sec><title>Expression of 3a protein in <italic>Xenopus oocytes</italic>
</title><p>To investigate effects of kaempferol and its derivatives on the 3a protein of
SARS-CoV, we used the <italic>Xenopus</italic> oocyte for heterologous expression and
applied voltage-clamp techniques (for details see <xref rid="RX0969-11" ref-type="bibr">11</xref>,&#x0200a;<xref rid="RX0969-13" ref-type="bibr">13</xref>). Females of the clawed toad
<italic>Xenopus laevis</italic> (Maosheng Bio-Technology Com.) were anaesthetized with
tricane (1&#x02009;g/L H<sub>2</sub>O, MS222; Sandoz) or in ice water. Parts of the
ovary were removed and treated with 0.3 units/mL Liberase (Roche) or with
1&#x02009;mg/mL Collagenase (Sigma) for 3 to 4&#x02009;h to remove enveloping tissue and to
obtain isolated oocytes. The entire procedure follows standard protocols
including care of laboratory animals that have been established according to
German Animal Protection Law. For expression of 3a protein, oocytes of stage V
or VI <xref rid="RX0969-34" ref-type="bibr">34</xref> were selected and injected with 20 or
30&#x02009;ng cRNA for 3a protein (for details see <xref rid="RX0969-11" ref-type="bibr">11</xref>)
(at 1&#x02009;ng/nL) two to three days before the experiments; uninjected oocytes served
as controls. The cells were stored for 2 days at 19&#x0200a;&#x000b0;C in oocyte Ringer&#x002bc;s-like
solution (G-ORi, see solutions). Experiments were performed at room temperature
(24&#x02013;26&#x0200a;&#x000b0;C).</p></sec><sec><title>Solutions</title><p>Standard ORi solution contained: 90&#x02009;mM NaCl, 2&#x02009;mM KCl, 2&#x02009;mM CaCl<sub>2</sub>, and
5&#x02009;mM Hepes (adjusted to pH&#x02009;7.4 with Tris). For cell incubation, the ORi was
supplemented with 70&#x02009;&#x000b5;g/L gentamycin (G-ORi).</p><p>Since the 3a protein channel showed high permeability to K<sup>+</sup>
<xref rid="RX0969-11" ref-type="bibr">11</xref>, the test solution without Ba<sup>2+</sup>
(S1) contained: 100&#x02009;mM KCl, 2&#x02009;mM MgCl<sub>2</sub>, and 5&#x02009;mM Hepes (pH&#x02009;7.4);
because the <italic>Xenopus</italic> oocytes express endogenous Ca<sup>2+</sup>-activated
K<sup>+</sup> and Cl<sup>&#x02212;</sup> channels, Ca<sup>2+</sup> was omitted from
the bath solutions (but replaced by Mg<sup>2+</sup>) to reduce these background
currents. Test solution S2 contained 10&#x02009;mM BaCl<sub>2</sub> in addition. The
change in osmolarity due to addition of BaCl<sub>2</sub> did not affect the
membrane currents. The difference between the current measured in S1 and S2 was
considered as the Ba<sup>2+</sup>-sensitive current component. Both solutions,
S1 and S2, contained some DMSO (see below).</p><p>All stock solutions of drugs were made up in DMSO. Kaempferol was purchased from
Sigma-Aldrich; two probes of the kaempferol glycosides (juglanin,
kaempferol-3-O-<italic>&#x003b1;</italic>-L-arabinofuranoside, and afzelin,
kaempferol-3-O-<italic>&#x003b1;</italic>-L-rhamnoside) were kindly provided by Prof. X. Hao
and Dr. Y. Wang, Kunming, China, or bought from BioBioPHa.</p><p>Kaempferol acylated glucosides were previously isolated from polar extracts from
the leaves of the plant <italic>Quercus ilex</italic> L. <xref rid="RX0969-35" ref-type="bibr">35</xref>; the kaempferol triglycoside was an isolate from <italic>Viola odorata</italic>
L. <xref rid="RX0969-36" ref-type="bibr">36</xref>. Isolation was carried out mainly by column
chromatography on Sephadex LH-20 and silica gel. The structure of the compounds
was established by NMR experiments. The purity was checked by NMR and
high-performance liquid chromatography with diode array detector and was over
95&#x0200a;%. Quercetin and naringenin were purchased from Sigma-Aldrich, and genistein
from Sinopharm Chemical Reagent Co., Ltd. The purities of all drugs are listed
in <xref rid="TBX0969-1" ref-type="table">Table 1</xref>.</p></sec><sec><title>Voltage&#x02013;clamp experiments</title><p>We applied conventional two-electrode voltage clamp using Turbo TEC-03 with
CellWorks software (NPI Electronic) to measure the current mediated by SARS-3a
protein. This method allowed directly monitoring modulations of the ion channel
function under various conditions including inhibition by drugs. Previously, we
had successfully applied this method to show that emodin (purity &#x0003e;&#x02009;95&#x0200a;%)
inhibits ion flow through the 3a protein ion channel <xref rid="RX0969-13" ref-type="bibr">13</xref>. To determine steady-state current&#x02013;voltage dependencies (IV
curves), membrane currents were averaged during the last 20&#x02009;ms of 200&#x02009;ms,
rectangular voltage pulses from &#x02212;&#x02009;150 to +&#x02009;30&#x02009;mV in 10-mV increments; the pulses
were applied from a holding potential of &#x02212;&#x02009;60&#x02009;mV. To avoid changes at the bath
electrodes due to changes in Cl<sup>&#x02212;</sup> activity, the electrodes were
uncoupled from the bath via ORi-filled channels.</p><p>Current mediated by the 3a protein can be blocked by Ba<sup>2+</sup>
<xref rid="RX0969-11" ref-type="bibr">11</xref>. Therefore, we determined
Ba<sup>2+</sup>-sensitive current as the difference of steady-state current in
the presence and absence of 10&#x02009;mM BaCl<sub>2</sub> (see Solutions). Since
oocytes which did not express 3a protein also exhibited some
Ba<sup>2+</sup>-sensitive current contribution, this endogenous component was
determined in uninjected control cells and used for subtraction from total
Ba<sup>2+</sup>-sensitive current of the injected oocytes from the same
batch. The difference was considered to represent 3a-mediated current.</p><p>To correct for possible drift with time, Ba<sup>2+</sup>-sensitive current was
calculated according to:</p><disp-formula id="DF-2"><alt-text>I_Ba-sensitive = (IS1_before - IS1_after)/2 - IS2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pmeq02.gif"/></disp-formula><p>or</p><disp-formula id="DF-3"><alt-text>I_Ba-sensitive = IS1 - (IS2_before - IS2_after)/2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10-1055-s-0033-1360277-ix0969pmeq03.gif"/></disp-formula><p>
<italic>IS</italic>1 and <italic>IS</italic>2 stand for current measurements in the absence and
presence of the Ba<sup>2+</sup>, respectively, the subscripts <sub>before</sub>
and <sub>after</sub> refer to measurements before and after the measurement with
the respective other solution. For a typical experiment, either of the following
sequences of solutions was used for perfusing the chamber with the oocyte:</p><p>S1&#x0200a;&#x02192;&#x0200a;S2&#x0200a;&#x02192;&#x0200a;S1&#x02009;<bold>&#x02192;</bold>&#x02009;S1+&#x0200a;&#x02192;&#x0200a;S2+&#x0200a;&#x02192;&#x0200a;S1+&#x02009;<bold>&#x02192;</bold>&#x02009;S1&#x0200a;&#x02192;&#x0200a;S2&#x0200a;&#x02192;&#x0200a;S1</p><p>S2&#x0200a;&#x02192;&#x0200a;S1&#x0200a;&#x02192;&#x0200a;S2&#x02009;<bold>&#x02192;</bold>&#x02009;S2+&#x0200a;&#x02192;&#x0200a;S1+&#x0200a;&#x02192;&#x0200a;S2+&#x02009;<bold>&#x02192;</bold>&#x02009;S2&#x0200a;&#x02192;&#x0200a;S1&#x0200a;&#x02192;&#x0200a;S2.</p><p>The + sign indicates solutions with the respective drug.</p></sec></sec><sec><title>Acknowledgements</title><p>We gratefully acknowledge the technical assistance from Huiming Du during the various
steps of this project. SS, DS, and WS thank Prof. Gu Quanbao for helpful
discussions. The work was supported by the National Basic Research Program of China
(973 Program, 2012CB518502). We also gratefully acknowledge the support from Green
Valley Holding Co, Shanghai.</p></sec></body><back><fn-group><fn fn-type="COI-statement" id="d30e195"><p><bold>Conflict of Interest</bold> All authors declare that there are no conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="RX0969-1"><label>1</label><mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Sauter</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Efferth</surname><given-names>T</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><article-title>Coronaviral ion channels as target for Chinese herbal medicine</article-title><source>Forum Immunopathol Dis Ther</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>13</lpage></mixed-citation></ref><ref id="RX0969-2"><label>2</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>M M</given-names></name><name><surname>Liu</surname><given-names>X M</given-names></name><name><surname>He</surname><given-names>L</given-names></name><article-title>Effect of integrated traditional Chinese and Western medicine on SARS: A review
of clinical evidence</article-title><source>World J Gastroenterol</source><year>2004</year><volume>10</volume><fpage>3500</fpage><lpage>3505</lpage><pub-id pub-id-type="pmid">15526373</pub-id></mixed-citation></ref><ref id="RX0969-3"><label>3</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>X M</given-names></name><name><surname>Zhang</surname><given-names>M M</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y P</given-names></name><name><surname>Kang</surname><given-names>Y K</given-names></name><article-title>Chinese herbs combined with Western medicine for severe acute respiratory
syndrome (SARS)</article-title><source>Cochrane Database Syst Rev</source><year>2006</year><issue>1</issue>CD004882</mixed-citation></ref><ref id="RX0969-4"><label>4</label><mixed-citation publication-type="journal"><name><surname>Fischer</surname><given-names>W B</given-names></name><name><surname>Thiel</surname><given-names>G</given-names></name><name><surname>Fink</surname><given-names>R HA</given-names></name><article-title>Viral membrane proteins</article-title><source>Eur Biophys J</source><year>2010</year><volume>39</volume><fpage>1041</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">19672588</pub-id></mixed-citation></ref><ref id="RX0969-5"><label>5</label><mixed-citation publication-type="journal"><name><surname>Kr&#x000fc;ger</surname><given-names>J</given-names></name><name><surname>Fischer</surname><given-names>W B</given-names></name><article-title>Assembly of viral membrane proteins</article-title><source>J Chem Theor Comput</source><year>2009</year><volume>5</volume><fpage>2503</fpage><lpage>2513</lpage></mixed-citation></ref><ref id="RX0969-6"><label>6</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><article-title>Viral proteins function as ion channels</article-title><source>Biochim Biophys Acta</source><year>2011</year><volume>1808</volume><fpage>510</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">20478263</pub-id></mixed-citation></ref><ref id="RX0969-7"><label>7</label><mixed-citation publication-type="book"><name><surname>Fischer</surname><given-names>W B</given-names></name><name><surname>Wang</surname><given-names>Y T</given-names></name><name><surname>Schindler</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>C Y</given-names></name><article-title>Mechanism of function of viral channel protein and implications for drug
development</article-title><publisher-loc>Burlington</publisher-loc><publisher-name>Elsevier Inc./Academic Press</publisher-name><year>2012</year><fpage>259</fpage><lpage>321</lpage></mixed-citation></ref><ref id="RX0969-8"><label>8</label><mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z Y</given-names></name><article-title>Ion channels as antivirus targets</article-title><source>Virol Sin</source><year>2010</year><volume>25</volume><fpage>267</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">20960300</pub-id></mixed-citation></ref><ref id="RX0969-9"><label>9</label><mixed-citation publication-type="journal"><name><surname>Kelly</surname><given-names>M L</given-names></name><name><surname>Cook</surname><given-names>J-A</given-names></name><name><surname>Brown-Augsburger</surname><given-names>P</given-names></name><name><surname>Heinz</surname><given-names>B A</given-names></name><name><surname>Smith</surname><given-names>M C</given-names></name><name><surname>Pinto</surname><given-names>L H</given-names></name><article-title>Demonstrating the intrinsic ion channel activity of virally encoded
proteins</article-title><source>FEBS Lett</source><year>2003</year><volume>552</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">12972153</pub-id></mixed-citation></ref><ref id="RX0969-10"><label>10</label><mixed-citation publication-type="journal"><name><surname>Montal</surname><given-names>M</given-names></name><article-title>Structure-function correlates of Vpu, a membrane protein of HIV-1</article-title><source>FEBS Lett</source><year>2003</year><volume>552</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12972151</pub-id></mixed-citation></ref><ref id="RX0969-11"><label>11</label><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>B J</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>L Y</given-names></name><name><surname>Wong</surname><given-names>C KL</given-names></name><name><surname>Chen</surname><given-names>J D</given-names></name><name><surname>Duan</surname><given-names>S M</given-names></name><name><surname>Deubel</surname><given-names>V</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><article-title>Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion
channel and modulates virus release</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>12540</fpage><lpage>12545</lpage><pub-id pub-id-type="pmid">16894145</pub-id></mixed-citation></ref><ref id="RX0969-12"><label>12</label><mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Sauter</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Efferth</surname><given-names>T</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><article-title>Coronaviral ion channels as target for Chinese herbal medicine</article-title><source>Forum Immunopathol Dis Ther</source><year>2012</year><volume>3</volume><fpage>1</fpage><lpage>13</lpage></mixed-citation></ref><ref id="RX0969-13"><label>13</label><mixed-citation publication-type="journal"><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><article-title>Emodin inhibits current through SARS-associated coronavirus 3a protein</article-title><source>Antivir Res</source><year>2011</year><volume>90</volume><fpage>64</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">21356245</pub-id></mixed-citation></ref><ref id="RX0969-14"><label>14</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Dang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><article-title>Anti-cancer natural products isolated from Chinese medicinal herbs</article-title><source>Chin Med</source><year>2011</year><volume>6</volume><fpage>27</fpage><pub-id pub-id-type="pmid">21777476</pub-id></mixed-citation></ref><ref id="RX0969-15"><label>15</label><mixed-citation publication-type="journal"><name><surname>Lown</surname><given-names>J W</given-names></name><article-title>Anthracycline and anthraquinone anticancer agents: Current status and recent
developments</article-title><source>Pharmacol Ther</source><year>1993</year><volume>60</volume><fpage>185</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">8022857</pub-id></mixed-citation></ref><ref id="RX0969-16"><label>16</label><mixed-citation publication-type="journal"><name><surname>Naithani</surname><given-names>R</given-names></name><name><surname>Huma</surname><given-names>L C</given-names></name><name><surname>Holland</surname><given-names>L E</given-names></name><name><surname>Shukla</surname><given-names>D</given-names></name><name><surname>McCormick</surname><given-names>D L</given-names></name><name><surname>Mehta</surname><given-names>R G</given-names></name><name><surname>Moriarty</surname><given-names>R M</given-names></name><article-title>Antiviral activity of phytochemicals: A comprehensive review</article-title><source>Minirev Med Chem</source><year>2008</year><volume>8</volume><fpage>1106</fpage><lpage>1133</lpage></mixed-citation></ref><ref id="RX0969-17"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lyu</surname><given-names>S-Y</given-names></name><name><surname>Rhim</surname><given-names>J-Y</given-names></name><name><surname>Park</surname><given-names>W-B</given-names></name><article-title>Antiherpetic activities of flavonoids against herpes simplex virus type 1
(HSV-1) and type 2 (SV-2) <italic>in vitro</italic></article-title><source>Arch Pharm Res</source><year>2005</year><volume>28</volume><fpage>1293</fpage><lpage>1301</lpage><pub-id pub-id-type="pmid">16350858</pub-id></mixed-citation></ref><ref id="RX0969-18"><label>18</label><mixed-citation publication-type="journal"><name><surname>Mitrocotsa</surname><given-names>D</given-names></name><name><surname>Mitaku</surname><given-names>S</given-names></name><name><surname>Axarlis</surname><given-names>S</given-names></name><name><surname>Harvala</surname><given-names>C</given-names></name><name><surname>Malamas</surname><given-names>M</given-names></name><article-title>Evaluation of the antiviral activity of kaempferol and its glycosides against
human cytomegalovirus</article-title><source>Planta Med</source><year>2000</year><volume>66</volume><fpage>377</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">10865462</pub-id></mixed-citation></ref><ref id="RX0969-19"><label>19</label><mixed-citation publication-type="journal"><name><surname>Nijveldt</surname><given-names>R J</given-names></name><name><surname>van Nood</surname><given-names>E</given-names></name><name><surname>van Hoorn</surname><given-names>D EC</given-names></name><name><surname>Boelens</surname><given-names>P G</given-names></name><name><surname>van Norren</surname><given-names>K</given-names></name><name><surname>Leeuwen</surname><given-names>P AM</given-names></name><article-title>Flavonoids: a review of probable mechanisms of action and potential
applications</article-title><source>Am J Clin Nutr</source><year>2001</year><volume>74</volume><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">11566638</pub-id></mixed-citation></ref><ref id="RX0969-20"><label>20</label><mixed-citation publication-type="journal"><name><surname>Kaul</surname><given-names>T N</given-names></name><name><surname>Middleton</surname><given-names>E</given-names></name><name><surname>Ogra</surname><given-names>P L</given-names></name><article-title>Antiviral effect of flavonoids on human viruses</article-title><source>J Med Virol</source><year>1985</year><volume>15</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">2981979</pub-id></mixed-citation></ref><ref id="RX0969-21"><label>21</label><mixed-citation publication-type="journal"><name><surname>Hollman</surname><given-names>P CH</given-names></name><article-title>Absorption, bioavailability, and metabolism of flavonoids</article-title><source>Pharm Biol</source><year>2004</year><volume>42</volume><fpage>74</fpage><lpage>83</lpage></mixed-citation></ref><ref id="RX0969-22"><label>22</label><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>T W</given-names></name><name><surname>Wu</surname><given-names>S L</given-names></name><name><surname>Chen</surname><given-names>J C</given-names></name><name><surname>Li</surname><given-names>C C</given-names></name><name><surname>Hsiang</surname><given-names>C Y</given-names></name><article-title>Emodin blocks the SARS coronavirus spike protein and angiotensin-converting
enzyme 2 interaction</article-title><source>Antivir Res</source><year>2007</year><volume>74</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">16730806</pub-id></mixed-citation></ref><ref id="RX0969-23"><label>23</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Liew</surname><given-names>O W</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Push</surname><given-names>C M</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><article-title>Binding interaction of quercetin-3-<italic>&#x003b2;</italic>-galactoside and its synthetic
derivatives with SARS-CoV 3&#x02009;CL<sup>pro</sup>: Structure activity relationship
studies reveal salient pharmacophore features</article-title><source>Bioorg Med Chem</source><year>2006</year><volume>14</volume><fpage>8295</fpage><lpage>8306</lpage><pub-id pub-id-type="pmid">17046271</pub-id></mixed-citation></ref><ref id="RX0969-24"><label>24</label><mixed-citation publication-type="journal"><name><surname>Lyu</surname><given-names>S Y</given-names></name><name><surname>Rhim</surname><given-names>J Y</given-names></name><name><surname>Park</surname><given-names>W B</given-names></name><article-title>Antiherpetic activities of flavonoids against herpes simplex virus type 1
(HSV-1) and type 2 (HSV-2) <italic>in vitro</italic></article-title><source>Arch Pharm Res</source><year>2005</year><volume>28</volume><fpage>1293</fpage><lpage>1301</lpage><pub-id pub-id-type="pmid">16350858</pub-id></mixed-citation></ref><ref id="RX0969-25"><label>25</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>A L</given-names></name><name><surname>Wang</surname><given-names>H D</given-names></name><name><surname>Lee</surname><given-names>S MY</given-names></name><name><surname>Wang</surname><given-names>Y T</given-names></name><name><surname>Du</surname><given-names>G H</given-names></name><article-title>Structure-activity relationship of flavonoids as influenza virus neuraminidase
inhibitors and their <italic>in vitro</italic> anti-viral activities</article-title><source>Bioorg Med Chem</source><year>2008</year><volume>16</volume><fpage>7141</fpage><lpage>7147</lpage><pub-id pub-id-type="pmid">18640042</pub-id></mixed-citation></ref><ref id="RX0969-26"><label>26</label><mixed-citation publication-type="journal"><name><surname>Evers</surname><given-names>D L</given-names></name><name><surname>Chao</surname><given-names>C F</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Huong</surname><given-names>S M</given-names></name><name><surname>Huang</surname><given-names>E S</given-names></name><article-title>Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and
mechanism of action</article-title><source>Antiviral Res</source><year>2005</year><volume>68</volume><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">16188329</pub-id></mixed-citation></ref><ref id="RX0969-27"><label>27</label><mixed-citation publication-type="journal"><name><surname>Thilakarathna</surname><given-names>S H</given-names></name><name><surname>Rupasinghe</surname><given-names>H PV</given-names></name><article-title>Flavonoid bioavailability and attempts for bioavailability enhancement</article-title><source>Nutrients</source><year>2013</year><volume>5</volume><fpage>3387</fpage></mixed-citation></ref><ref id="RX0969-28"><label>28</label><mixed-citation publication-type="journal"><name><surname>Walle</surname><given-names>T</given-names></name><article-title>Absorption and metabolism of flavonoids</article-title><source>Free Radic Biol Med</source><year>2004</year><volume>36</volume><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">15019968</pub-id></mixed-citation></ref><ref id="RX0969-29"><label>29</label><mixed-citation publication-type="book"><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><article-title>SARS accessory proteins ORF3a and 9b and their functional analysis</article-title><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer</publisher-name><year>2010</year><fpage>167</fpage><lpage>175</lpage></mixed-citation></ref><ref id="RX0969-30"><label>30</label><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Frey</surname><given-names>T K</given-names></name><name><surname>Yang</surname><given-names>J J</given-names></name><article-title>Viral calciomics: Interplays between Ca2+ and virus</article-title><source>Cell Calcium</source><year>2009</year><volume>46</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">19535138</pub-id></mixed-citation></ref><ref id="RX0969-31"><label>31</label><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Gage</surname><given-names>P</given-names></name><name><surname>Ewart</surname><given-names>G</given-names></name><article-title>Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus
replication</article-title><source>Virology</source><year>2006</year><volume>353</volume><fpage>294</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">16815524</pub-id></mixed-citation></ref><ref id="RX0969-32"><label>32</label><mixed-citation publication-type="journal"><name><surname>Luscombe</surname><given-names>C A</given-names></name><name><surname>Huang</surname><given-names>Z H</given-names></name><name><surname>Murray</surname><given-names>M G</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Ilkinson</surname><given-names>J</given-names></name><name><surname>Ewart</surname><given-names>G D</given-names></name><article-title>A novel Hepatitis C virus p&#x0200a;7 ion channel inhibitor, BIT225, inhibits bovine
viral diarrhea virus <italic>in vitro</italic> and shows synergism with recombinant
interferon-<italic>&#x003b1;</italic>-2b and nucleoside analogues</article-title><source>Antivir Res</source><year>2010</year><volume>86</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">20156486</pub-id></mixed-citation></ref><ref id="RX0969-33"><label>33</label><mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>S Q</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><name><surname>Schwarz</surname><given-names>W</given-names></name><name><surname>Jin</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><article-title>DIDS blocks a chloride-dependent current that is mediated by the 2B protein of
enterovirus 71</article-title><source>Cell Res</source><year>2011</year><volume>21</volume><fpage>1271</fpage><lpage>1275</lpage><pub-id pub-id-type="pmid">21747413</pub-id></mixed-citation></ref><ref id="RX0969-34"><label>34</label><mixed-citation publication-type="journal"><name><surname>Dumont</surname><given-names>J N</given-names></name><article-title>Oogenesis in &#x0201c;<italic>Xenopus laevis</italic>&#x0201d; (Daudin): I. Stages of oocyte development
in laboratory maintained animals</article-title><source>J Morphol</source><year>1972</year><volume>136</volume><fpage>153</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">4109871</pub-id></mixed-citation></ref><ref id="RX0969-35"><label>35</label><mixed-citation publication-type="journal"><name><surname>Karioti</surname><given-names>A</given-names></name><name><surname>Bilia</surname><given-names>A R</given-names></name><name><surname>Skaltsa</surname><given-names>H</given-names></name><article-title><italic>Quercus ilex</italic> L.: A rich source of polyacylated flavonoid glucosides</article-title><source>Food Chem</source><year>2010</year><volume>123</volume><fpage>131</fpage><lpage>142</lpage></mixed-citation></ref><ref id="RX0969-36"><label>36</label><mixed-citation publication-type="journal"><name><surname>Karioti</surname><given-names>A</given-names></name><name><surname>Furlan</surname><given-names>C</given-names></name><name><surname>Vincieri</surname><given-names>F F</given-names></name><name><surname>Bilia</surname><given-names>A R</given-names></name><article-title>Analysis of the constituents and quality control of <italic>Viola odorata</italic> aqueous
preparations by HPLC-DAD and HPLC-ESI-MS</article-title><source>Anal Bioanal Chem</source><year>2011</year><volume>399</volume><fpage>1715</fpage><lpage>1723</lpage><pub-id pub-id-type="pmid">21153584</pub-id></mixed-citation></ref></ref-list></back></article>